BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38263760)

  • 1. Neurological outcome in long-chain hydroxy fatty acid oxidation disorders.
    Mütze U; Ottenberger A; Gleich F; Maier EM; Lindner M; Husain RA; Palm K; Beblo S; Freisinger P; Santer R; Thimm E; Vom Dahl S; Weinhold N; Grohmann-Held K; Haase C; Hennermann JB; Hörbe-Blindt A; Kamrath C; Marquardt I; Marquardt T; Behne R; Haas D; Spiekerkoetter U; Hoffmann GF; Garbade SF; Grünert SC; Kölker S
    Ann Clin Transl Neurol; 2024 Apr; 11(4):883-898. PubMed ID: 38263760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.
    Lotz-Havla AS; Röschinger W; Schiergens K; Singer K; Karall D; Konstantopoulou V; Wortmann SB; Maier EM
    Orphanet J Rare Dis; 2018 Jul; 13(1):122. PubMed ID: 30029694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.
    Fraser H; Geppert J; Johnson R; Johnson S; Connock M; Clarke A; Taylor-Phillips S; Stinton C
    Orphanet J Rare Dis; 2019 Nov; 14(1):258. PubMed ID: 31730477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic, biochemical, and clinical spectrum of patients with mitochondrial trifunctional protein deficiency identified after the introduction of newborn screening in the Netherlands.
    Schwantje M; Fuchs SA; de Boer L; Bosch AM; Cuppen I; Dekkers E; Derks TGJ; Ferdinandusse S; Ijlst L; Houtkooper RH; Maase R; van der Pol WL; de Vries MC; Verschoof-Puite RK; Wanders RJA; Williams M; Wijburg F; Visser G
    J Inherit Metab Dis; 2022 Jul; 45(4):804-818. PubMed ID: 35383965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of newborn screening for fatty acid oxidation disorders on neurological outcome: A Belgian retrospective and multicentric study.
    Everard E; Laeremans H; Boemer F; Marie S; Vincent MF; Dewulf JP; Debray FG; De Laet C; Nassogne MC
    Eur J Paediatr Neurol; 2024 Mar; 49():60-65. PubMed ID: 38377647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermo-sensitive mitochondrial trifunctional protein deficiency presenting with episodic myopathy.
    Schwantje M; Ebberink MS; Doolaard M; Ruiter JPN; Fuchs SA; Darin N; Hedberg-Oldfors C; Régal L; Donker Kaat L; Huidekoper HH; Olpin S; Cole D; Moat SJ; Visser G; Ferdinandusse S
    J Inherit Metab Dis; 2022 Jul; 45(4):819-831. PubMed ID: 35403730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein.
    Grünert SC; Eckenweiler M; Haas D; Lindner M; Tsiakas K; Santer R; Tucci S; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):893-902. PubMed ID: 33638202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial bioenergetics deregulation caused by long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies in rat brain: a possible role of mPTP opening as a pathomechanism in these disorders?
    Tonin AM; Amaral AU; Busanello EN; Gasparotto J; Gelain DP; Gregersen N; Wajner M
    Biochim Biophys Acta; 2014 Sep; 1842(9):1658-67. PubMed ID: 24946182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
    Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
    BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria.
    Tonin AM; Amaral AU; Busanello EN; Grings M; Castilho RF; Wajner M
    J Bioenerg Biomembr; 2013 Feb; 45(1-2):47-57. PubMed ID: 23065309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and progressive retinopathy: one case report followed by ERGs, VEPs, EOG over a 17-year period.
    Rigaudière F; Delouvrier E; Le Gargasson JF; Milani P; Ogier de Baulny H; Schiff M
    Doc Ophthalmol; 2021 Jun; 142(3):371-380. PubMed ID: 33392894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbance of mitochondrial functions provoked by the major long-chain 3-hydroxylated fatty acids accumulating in MTP and LCHAD deficiencies in skeletal muscle.
    Cecatto C; Godoy KDS; da Silva JC; Amaral AU; Wajner M
    Toxicol In Vitro; 2016 Oct; 36():1-9. PubMed ID: 27371118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
    Han Y; Yang Z; Ding X; Yu H; Yi Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):740-6. PubMed ID: 26675572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.
    Potter BK; Little J; Chakraborty P; Kronick JB; Evans J; Frei J; Sutherland SC; Wilson K; Wilson BJ
    J Inherit Metab Dis; 2012 Jan; 35(1):115-23. PubMed ID: 21630065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study.
    Rücklová K; Hrubá E; Pavlíková M; Hanák P; Farolfi M; Chrastina P; Vlášková H; Kousal B; Smolka V; Foltenová H; Adam T; Friedecký D; Ješina P; Zeman J; Kožich V; Honzík T
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variation of long-chain 3-hydroxyacyl CoA dehydrogenase DNA methylated modification and correlation with gene mRNA expression of early-onset preeclampsia, HELLP syndrome and antiphospholipid syndrome in trophoblast cells of placenta].
    Meng R; Yang Z; Wang HL; Han YW; Wang YL; Yu H
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):270-8. PubMed ID: 27116985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETINAL PHENOTYPE IN A CASE OF LCHAD/TFP DEFICIENCY WITH LATE-STAGE DIAGNOSIS.
    Knowles JA; Dimopoulos IS; MacDonald IM
    Retin Cases Brief Rep; 2019 Summer; 13(3):279-282. PubMed ID: 28301411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults.
    Nadjar Y; Souvannanorath S; Maisonobe T; Brisset M; De Lonlay P; Schiff M; Viala K; Boutron A; Nicolas G; Laforêt P
    Rev Neurol (Paris); 2020 May; 176(5):380-386. PubMed ID: 32253025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral neuropathy in patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency - A follow-up EMG study of 12 patients.
    Immonen T; Ahola E; Toppila J; Lapatto R; Tyni T; Lauronen L
    Eur J Paediatr Neurol; 2016 Jan; 20(1):38-44. PubMed ID: 26653362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.